AstraZeneca to Create $1B Fund, R&D Centers in China
AstraZeneca’s China headquarters at Shanghai Zhangjiang Hi-Tech Park
AstraZeneca said today it will create new R&D centers focused on drug development and artificial intelligence (AI) in Shanghai, as well as partner with state-run China International...
Self-Propelling Nanobots Reduce Bladder Tumor Size by 90% in Mice
Researchers led by teams at the Institute for Bioengineering of Catalonia (IBEC) and CIC biomaGUNE demonstrated how a single dose of urea-powered, radionuclide-carrying nanorobots successfully reduced the size of bladder tumors in mice by...
New Exoplanet Candidate Discovered Beyond Our Solar System
In a groundbreaking development in the field of exoplanet research, scientists at the University of New South Wales (UNSW) Sydney have identified a potential new exoplanet using an advanced method known as transit timing...
Perspectives of tumor treatment: Researchers investigate combination of carbon ion and immunotherapy
Credit: Adrian Rodríguez Rodríguez/GSI
It is still a glance into the future: The combination of carbon ion and immune therapy could become an effective tool in the...
Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform
Rentschler Biopharma signed a license agreement with Horizon Discovery to use Horizon’s CHOSOURCE platform in combination with Rentschler’s in-house process for cell line development for difficult-to-express proteins. Horizon’s gene-edited Glutamine Synthetase (GS) knockout CHO...
InnovationAus 2021 Awards: Medtech and Biotechnology finalists revealed – https://www.innovationaus.com/
There has never been more attention on Australia’s medtech and biotechnology industry, with the COVID-19 pandemic shining a spotlight on the sector and its importance to the country’s health and economy.
Australia already has...
Scientific Data Crisis Holds Back CMC
A biopharmaceutical industry executive recently shared a telling insight with one of my colleagues. He said all his peers want to “pick out the drapes in the penthouse of AI-powered drug development, but everyone...
A defense against attacks on unmanned ground and aerial vehicles
A University of Texas at Arlington engineering researcher is working on defenses that could thwart cyberattacks against networks of self-driving cars and unmanned aerial vehicles.
Credit: UT Arlington
A University of Texas at Arlington engineering researcher...
Cell and Gene Therapies: From Concept to Commercialization
REGISTER NOW
Broadcast Date: April 20, 2021Time: 8:00 am PT, 11:00 am ET, 17:00 CET The voyage of a cell or gene therapy from initial hypothesis to commercial delivery is complex and challenging. It requires...
Towards more efficient catalysts
Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS), Harvard Department of Chemistry & Chemical Biology, and Utrecht University have reported on a previously elusive way to improve the selectivity of catalytic reactions, adding a new...
